1. Home
  2. ATHM vs RCUS Comparison

ATHM vs RCUS Comparison

Compare ATHM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

N/A

Current Price

$19.87

Market Cap

2.5B

Sector

Technology

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$19.55

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATHM
RCUS
Founded
2008
2015
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
ATHM
RCUS
Price
$19.87
$19.55
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$28.00
$28.22
AVG Volume (30 Days)
450.1K
913.0K
Earning Date
01-01-0001
05-28-2026
Dividend Yield
8.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
$12.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.09
$6.79
52 Week High
$31.40
$26.40

Technical Indicators

Market Signals
Indicator
ATHM
RCUS
Relative Strength Index (RSI) 29.39 43.81
Support Level N/A $8.86
Resistance Level $23.60 $21.55
Average True Range (ATR) 0.64 1.09
MACD -0.06 0.03
Stochastic Oscillator 16.60 36.70

Price Performance

Historical Comparison
ATHM
RCUS

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: